Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

 148.30p
   
  • Change Today:
      0.000p
  • 52 Week High: 162.10
  • 52 Week Low: 94.55
  • Currency: UK Pounds
  • Shares Issued: 734.84m
  • Volume: 0
  • Market Cap: 1,089.77m
  • RiskGrade: 314

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

1 Day Chart (28-07-2021)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -24.1% 16.5%
ROCE n/a  
Latest F'cast
P/E 25.7 17.0
PEG n/a 0.3
Pr/Revenue 2.3 2.2
Pr/Book 18.5  
Latest F'cast
Revenue -17.6% -43.0%
PBT n/a n/a
EPS -66.7% 52.3%
DPS n/a n/a

Indivior Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 1,058.00 98.00 35.00¢ 11.8 3.9 +3% n/a 0.0%
31-Dec-17 1,093.00 137.00 37.00¢ 15.4 2.6 +6% n/a 0.0%
31-Dec-18 1,005.00 278.00 37.00¢ 4.2 n/a n/a n/a 0.0%
31-Dec-19 785.00 180.00 24.00¢ 2.3 n/a -35% n/a 0.0%
31-Dec-20 647.00 (173.00) 8.00¢ 19.0 n/a -67% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Indivior Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 514.11 84.57 8.86p 16.7 0.3 +52% n/a 0.0%
31-Dec-22 549.52 127.00 13.55p 10.9 0.2 +53% n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Indivior Company Announcements

Half-year Report 29-Jul-2021 07:00 RNS
Notice of Results 14-Jul-2021 07:00 RNS
Holding(s) in Company 07-Jul-2021 14:09 RNS

Latest Indivior Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Indivior Market Data

Currency UK Pounds
Share Price 148.30p
Change Today 0.000p
% Change 0.00 %
52 Week High 162.10
52 Week Low 94.55
Volume 0
Shares Issued 734.84m
Market Cap 1,089.77m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.59% below the market average5.59% below the market average5.59% below the market average5.59% below the market average5.59% below the market average
92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average
Price Trend
31.27% above the market average31.27% above the market average31.27% above the market average31.27% above the market average31.27% above the market average
34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average
Income Not Available
Growth
68.54% below the market average68.54% below the market average68.54% below the market average68.54% below the market average68.54% below the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for --2021

Time Volume / Share Price
0 @ 0.000p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page